Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06429332
PHASE4

International Care Bundle Evaluation in Cerebral Hemorrhage Research

Sponsor: Region Skane

View on ClinicalTrials.gov

Summary

Spontaneous intracerebral haemorrhage (ICH) accounts for approximately 10-15% of all strokes but stands for 50% of stroke-related morbidity and mortality. Approximately half of all patients with ICH have a decreased level of consciousness at hospital admission. Despite this, intensive care and neurosurgical interventions are uncommon. A study conducted in low- and middle-income countries has demonstrated a beneficial effect of a treatment package consisting of early intensive blood pressure lowering, as well as the treatment of pyrexia and elevated blood glucose levels. The I-CATCHER team is now planning to conduct a similar study in Sweden and Australia, as well as in other high-income countries. The study has a clear focus on implementation, aiming to improve treatment and prognosis for patients with ICH within a few years. The purpose of I-CATCHER is to investigate whether a structured treatment package (Care Bundle) improves 3-month prognosis in patients with spontaneous ICH compared to standard care.

Official title: International Care Bundle Evaluation in Cerebral Hemorrhage Research - a Batched Parallel Cluster-randomized Trial With a Baseline Period

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

3500

Start Date

2025-01-07

Completion Date

2027-07

Last Updated

2026-02-09

Healthy Volunteers

No

Interventions

OTHER

Reversal of Oral anticoagulation within 30 minutes

In situations of either an elevated INR with the use of warfarin - treatment with either 3- or 4-factor prothrombin complex concentrate (PCC) or fresh frozen plasma (FFP) within 30 minutes of ICH diagnosis on NCCT to reach and maintain an INR target \<1.3; or where there has been recent use (\<48 hours) of a direct oral anticoagulant (DOAC), use of an appropriate reversal agent within 30 minutes, where available, and according to local approvals.

OTHER

Early intensive blood pressure lowering

A systolic blood pressure (BP) target of 130-140 mmHg within 30 minutes of ICH diagnosis on NCCT is strived for, and to maintain this BP level for the first 7 days (for patients presenting with blood pressure \<200 mmHg). If blood pressure ≥200 and \<220, a target BP of 160 mmHg should be targeted at 30 minutes, and 130-140 mmHg should be achieved in 60 minutes. If BP ≥220, target BP of 160 mmHg and should be achieved in 60 minutes.

OTHER

Treatment of pyrexia

To achieve a body temperature target \<37.5 °C within the first 24h following ICH diagnosis on NCCT

OTHER

Hyperglycemia treatment

To maintain a blood glucose level 7-10 mmol/L within the first 24h following ICH diagnosis on NCCT

OTHER

Do-not-resuscitate (DNR) or withdrawal of care

Refrain from the use of DNR or withdrawal of care orders for 48 hours

OTHER

Referral to Intensive Care

Immediate (\<30 min) referral to intensive care if airway, breathing and/or circulation are compromized

OTHER

Referral to Neurosurgery

Immediate (\<30 min) referral to neurosurgery if any of the following criteria are fulfilled: * Large and/or rapidly evolving supratentorial ICH (\>20 ml volume) * Any intraventricular extension * Posterior fossa bleed, irrespective of volume * Suspicion of a vascular malformation, independent of volume or location * Reduction in reaction to sensory stimulation or drowsiness

DIAGNOSTIC_TEST

Repeat brain imaging

Repeat 6-12-hour brain imaging with the physicians choice of modality, preferably computed tomography (CT), if clinical deterioration or the patient received OAC reversal treatment

OTHER

Standard care

For patients in the usual-care group, decisions about the location of care delivery, investigations, monitoring, and all treatments are made by the treating clinical team. Data will be collected regarding the management of patients, including insertion of invasive monitoring devices, intravenous fluid resuscitation, BP lowering, vasoactive support, glycemic control, mechanical ventilation, neurosurgery, and other supportive therapy.

Locations (52)

The University of Oklahoma Health

Oklahoma City, Oklahoma, United States

Royal Adelaide Hospital

Adelaide, Australia

Monash Medical Centre

Clayton, Australia

The George Institute for Global Health

Sydney, Australia

Ottawa Hospital Research Institute

Ottawa, Ontario, Canada

Hong Kong University Hospital

Hong Kong, Hong Kong

Landspitali University Hospital

Reykjavik, Iceland

Avezzano Ospedale SS. Filippo e Nicola

Avezzano, Italy

Citta di Castello Ospedale Città di Castello

Città di Castello, Italy

Gubbio Ospedale di Gubbio e Gualdo Tadino

Gubbio, Italy

Azienda Ospedaliera Santa Maria della Misericordia Perugia

Perugia, Italy

Roma Policlinico Gemelli

Roma, Italy

National University of Malaysia Hospital

Kuala Lumpur, Malaysia

Universiti Putra Malaysia Hospital

Serdang, Malaysia

Höglandssjukhuset i Eksjö

Eksjö, Sweden

Sahlgrenska Universitetssjukhuset

Gothenburg, Sweden

Östra Sjukhuset

Gothenburg, Sweden

Hässleholms Sjukhus

Hässleholm, Sweden

Helsingborgs Lasarett

Helsingborg, Sweden

Karolinska Universitetssjukhuset Huddinge

Huddinge, Sweden

Länssjukhuset Ryhov

Jönköping, Sweden

Länssjukhuset Kalmar

Kalmar, Sweden

Blekingesjukhuset Karlskrona

Karlskrona, Sweden

Blekingesjukhuset

Karlskrona, Sweden

Centralsjukhuset Karlstad

Karlstad, Sweden

Västmanlands sjukhus Köping

Köping, Sweden

Centralsjukhuset Kristianstad

Kristianstad, Sweden

Kungälvs sjukhus

Kungälv, Sweden

Univeristetssjukhuset Linköping

Linköping, Sweden

Ljungby Lasarett

Ljungby, Sweden

Skåne University Hospital Lund Neurosurgery dept

Lund, Sweden

Skåne University Hospital Lund

Lund, Sweden

Region Skåne, Skåne University Hospital in Malmö, Department of Neurology

Malmo, Sweden

Mölndals Sjukhus

Mölndal, Sweden

Oskarshamn Sjukhus

Oskarshamn, Sweden

Universitetssjukhuset Örebro

Örebro, Sweden

Östersunds Lasarett

Östersund, Sweden

Skaraborgs Sjukhus Skövde

Skövde, Sweden

Capio St Görans Sjukhus

Stockholm, Sweden

Södersjukhuset

Stockholm, Sweden

Karolinska Universitetssjukhuset Solna

Stockholm, Sweden

Danderyds sjukhus

Stockholm, Sweden

Länssjukhuset Sundsvall

Sundsvall, Sweden

Norra Älvsborgs Länssjukhus

Trollhättan, Sweden

Norrlands Universitetssjukhus

Umeå, Sweden

Lasarettet i Enköping

Uppsala, Sweden

Akademiska Sjukhuset Uppsal

Uppsala, Sweden

Hallands sjukhus Varberg

Varberg, Sweden

Centrallasarettet Växjö

Vaxjo, Sweden

Värnamo sjukhus

Värnamo, Sweden

Västerås

Västerås, Sweden

Ystads lasarett

Ystad, Sweden